IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 51 a 100 di 227
Titolo Data di pubblicazione Autore(i) File
Efficacy of tuemor necrosis factor alfa blockade with infliximab for the treatment of svere steroid-refractory acute graft versus host disease. 1-gen-2004 Patriarca, Francesca; Sperotto, A.; Prosdocimo, S.; Damiani, Daniela; Morreale, G.; Olivieri, A.; Bonifazi, F.; Milone, G.; Peccatori, J.; Corradini, P.; Fanin R., on behalf of GITMO
Graft versus leukemia effect of donor lymphocyte reinfusions in acute leukemia patients relapsing after allogenic stem cell transplantation 1-gen-2004 Calistri, E.; Patriarca, Francesca; Filì, C.; Sperotto, A.; Geromin, A.; Zaja, Francesco; Candoni, A.; Prosdocimo, S.; Tiribelli, Mario; Damiani, Daniela; Fanin, R.
Successful treatment of hematological and extramedullary relapse of MLL-positive acute lymphoblastic leukemia after bone marrow transplantation using donor leukocyte infusion 1-gen-2004 Patriarca, Francesca; Sperotto, A; Skert, C; Damiani, Daniela; Prosdocimo, S; Fanin, Renato
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation 1-gen-2004 Patriarca, Francesca; Skert, C; Sperotto, A; Damiani, Daniela; Cerno, M; Geromin, A; Zaja, Francesco; Stocchi, R; Prosdocimo, S; Fili', C; Fanin, Renato
Effect of age and previous autologous transplantation on nonrelapse mortalità and survival in patients treated with reduced –intensity conditioninig and allografting for advanced hematologic malignancies 1-gen-2005 Corradini, P; Zallio, F; Mariotti, J; Farina, L; Bregni, M; Valagussa, P; Ciceri, F; Bacigalupo, A; Dodero, A; Lucesole, M; Patriarca, Francesca; Rambaldi, A; Scim, R; Locasciulli, A; Bandini, G; Gianni, Am; Tarella, C; Olivieri, A.
Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion. 1-gen-2005 Skert, C; Patriarca, Francesca; Zaja, Francesco; Tomadini, V; Fanin, Renato
Slerodermatous chronic graft versus host disease after allogeneic hematopoieitc stem cell transplantation: incidence, out come and risk factors. 1-gen-2005 Skert, C.; Patriarca, Francesca; Damiani, Daniela; Cerno, M. l.; Filì, C.; Geromin, A.; Sperotto, A.; Fanin, R.
Outcome of acute graft versus host disease after haematopoietic stem cell transplantation from sibling donor: a single centre experience. 1-gen-2005 Filì, C.; Patriarca, Francesca; Sperotto, A.; Skert, C.; Damiani, Daniela; Cernom, ; Calistri, E.; Candoni, A.; Buttignol, S.; Prosdocimo, S.; Fanin, R.
Prognostic factors and out come of late onset non infectious pulmonary complications after stem cell transplantation 1-gen-2005 Patriarca, Francesca; Skert, C.; Filì, C.; Sperotto, A.; Zaja, Francesco; Prosdocimo, S.; Damiani, Daniela; Cerno, M.; Geromin, A; Stocchi, R.; Fanin, R.
Cytokines disregulation and chronic graft versus host disease after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning 1-gen-2005 Skert, C.; Damiani, Daniela; Michelutti, A.; Stocchi, R.; Calistri, E.; Patriarca, Francesca; Cerno, M.; Fanin, R.
Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation. 1-gen-2005 Patriarca, Francesca; Prosdocimo, S; Tomadini, V; Vasciaveo, A; Bruno, B; Fanin, Renato
Cytokines dysregulation and chronic graft versus host disease after allogeneic haematopoieitc stem cell transplantation with reduced intensity conditioning 1-gen-2005 Skert, C; Damiani, Daniela; Michelutti, A; Stocchi, R; Calistri, E; Patriarca, Francesca; Cerno, M; Fanin, Renato
Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation 1-gen-2006 Bruno, B; Patriarca, F; Sorasio, R; Mattei, D; Montefusco, V; Peccatori, J; Bonifazi, F; Petrucci, Mt; Milone, G; Guidi, S; Giaccone, L; Rotta, M; Fanin, R; Boccadoro, M; Corradini, P
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation. 1-gen-2006 Patriarca, Francesca; Skert, C; Bonifazi, F; Sperotto, A; Fili, C; Stanzani, M; Zaja, Francesco; Cerno, M; Geromin, A; Bandini, G; Baccarani, M; Fanin, Renato
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia 1-gen-2006 Zaja, Francesco; Vianelli, N; Battista, M; Sperotto, A; Patriarca, Francesca; Tomadini, V; Filì, C; Tani, M; Baccarani, M; Fanin, Renato
Chronic GVHD and sequential study of cytokine patterns and lymphocyte subsets in patients underwent allogeneic stem cell transplantation with reduced intensity conditioning 1-gen-2006 Skert, C; Damiani, Daniela; Patriarca, Francesca; Michelutti, A; Filì, C; Zaja, Francesco; Sperotto, A; Cerno, M; Geromin, A; Candoni, A; Battista, M; Malagola, M; Roccaro, A; Bergonzi, C; Russo, D; Fanin, R.
Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome 1-gen-2006 Skert, C; Patriarca, Francesca; Sperotto, A; Cerno, M; Fili, C; Zaja, Francesco; Stocchi, R; Geromin, A; Damiani, Daniela; Fanin, Renato
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery 1-gen-2006 Patriarca, Francesca; Skert, C; Sperotto, A; Zaja, Francesco; Falleti, E; Mestroni, R; Kikic, F; Calistri, E; Fili, C; Geromin, A; Cerno, M; Fanin, Renato
Sequential study of cytokine and lymphocyte patterns in patients with chronic agraft versus host disease after reduced intensity conditioning allogenic stem cell transplantation 1-gen-2007 Skert, C.; Damiani, Daniela; Michelutti, A.; Patriarca, Francesca; Filì, C.; Malagola, M.; Bergonzi, C.; Roccaro, A.; Ricotta, D.; Caimi, L.; Fanin, R.; Russo, D.
Unrelated donor haematopietic cell transplantation after non-myeloablative conditioning for patients wuth high-risk myeloma 1-gen-2007 Bruno, B.; Sorasio, R.; Patriarca, Francesca; Montefusco, V.; Guidi, S.; Busca, A.; Scime, R.; Console, G.; Milone, G.; Marotta, G.; Dominietto, A.; Giaccone, L.; Rotta, M.; Falda, M.; Bacigalupo, A.; Bosi, A.; Corradini, P.; Fanin, Renato; Pollichieni, S.; Boccadoro, M.
A prospective comparison of 18 F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disaese in newly diagnosed multiple myeloma 1-gen-2007 Zamagni, E; Nanni, C; Patriarca, Francesca; Englaro, E; Castellucci, P; Geatti, O; Tosi, P; Tacchetti, P; Cangini, D; Perrone, G; Ceccolini, M; Brioli, A; Buttignol, S; Fanin, Renato; Salizzoni, E; Baccarani, M; Fanti, S; Cavo, M.
Boertezomib after allografting in multiple myeloma: association between neurotoxicity and cyclosporine treatment 1-gen-2007 Giaccone, L; Sorasio, R; Patriarca, Francesca; Mattei, D; Montefusco, V; Peccatori, J; Carnevale Schianca, F; Petrucci, Mt; Milone, G; Guidi, S; Rotta, M; Fanin, Renato; Corradini, P; Boccadoro, M; Bruno, B.
A comparison of allografting with autografting for newly diagnosed myeloma 1-gen-2007 Bruno, B; Rotta, M; Patriarca, Francesca; Mordini, N; Allione, B; Carnevale Schianca, F; Giaccone, L; Sorasio, R; Omede'P, ; Baldi, I; Bringhen, S; Massaia, M; Aglietta, M; Levis, A; Gallamini, A; Fanin, Renato; Palumbo, A; Storb, R; Ciccone, G; Boccadoro, M.
Treatment of refractory chronic GVHD with rituximab: a GITMO study 1-gen-2007 Zaja, F; Bacigalupo, A; Patriarca, F; Stanzani, M; VAN LINT, M. T.; Filì, C; Scime, R; Milone, G; Falda, M; Vener, C; Laszlo, D; Alessandrino, P. E.; Narni, F; Sica, S; Olivieri, A; Sperotto, A; Bosi, A; Bonifazi, F; Fanin, R
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study 1-gen-2007 Cavo, M; Tosi, P; Zamagni, E; Cellini, C; Tacchetti, P; Patriarca, Francesca; Di Raimondo, F; Volpe, E; Ronconi, S; Cangini, D; Narni, F; Carubelli, A; Masini, L; Catalano, L; Fiacchini, M; de Vivo, A; Gozzetti, A; Lazzaro, A; Tura, S; Baccarani, M.
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype haevily influence outcome 1-gen-2007 Corradini, P; Dodero, A; Farina, L; Fanin, R; Patriarca, F; Miceli, R; Matteucci, P; Bregni, M; Scime', R; Narni, F; Pogliani, E; Locasciulli, A; Milani, R; Carniti, C; Bacigalupo, A; Rambaldi, A; Bonifazi, F; Olivieri, A; Gianni, Am; Tarella, C
Defibrotide : review on clinical use and future development 1-gen-2008 Larocca, A; Cavallo, F; Magarotto, V; Rossi, D; Patriarca, Francesca; Boccadoro, M; Palumbo, A. .
Chronic renal failure after haematopoietic transplantation. 1-gen-2008 Boscutti, G; Pizzolitto, S; Patriarca, Francesca; De Maglio, G; Bosco, M; Boer, E.
T-cell chimerism and clinical outcome after reduced-intensity conditioning allogeneic stem cell transplantation 1-gen-2008 Toffoletti, Eleonora; Patriarca, Francesca; Chiarvesio, A.; Michelutti, A.; Sperotto, A.; Cavallin, M.; Battista, M. L.; Zaja, Francesco; Fanin, Renato
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura 1-gen-2008 Zaja, Francesco; Battista, Ml; Pirrotta, Mt; Palmieri, S; Montagna, M; Vianelli, N; Marin, L; Cavallin, M; Bocchia, M; Defina, M; Ippoliti, M; Ferrara, F; Patriarca, Francesca; Avanzini, Ma; Regazzi, M; Baccarani, M; Isola, Miriam; Soldano, F; Fanin, Renato
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results 1-gen-2008 Medeot, M; Zaja, Francesco; Vianelli, N; Battista, M; Baccarani, M; Patriarca, Francesca; Soldano, F; Isola, Miriam; DE LUCA, S; Fanin, Renato
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)” 1-gen-2008 Patriarca, Francesca; Bacigalupo, A; Sperotto, A; Isola, Miriam; Soldano, F; Bruno, B; VAN LINT, Mt; Iori, Ap; Santarone, S; Porretto, F; Pioltelli, P; Visani, G; Iacopino, P; Fanin, Renato; Bosi, A.
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 1-gen-2009 Toffoletti, Eleonora; Patriarca, Francesca; Cavallin, M.; Sperotto, A.; Battista, M. L.; Michelutti, A.; Medeot, M.; Damiani, Daniela; Fanin, Renato
FEASIBILITY AND OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS WITH POOR RISK ACUTE MYELOID LEUKEMIA 1-gen-2009 Candoni, A.; Simeone, E.; Sperotto, A.; Geromin, A.; Cerno, M.; Patriarca, Francesca; Zaja, Francesco; Damiani, Daniela; Fanin, R.
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 1-gen-2009 Sperotto, A.; Patriarca, Francesca; Zaja, Francesco; Geromin, A.; Cerno, M.; Battista, M.; Medeot, M.; Toffoletti, E.; Damiani, Daniela; Fanin, R.
OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANT FOR REFRACTORY AND RELAPSED ACUTE MYELOID LEUKEMIA 1-gen-2009 Geromin, A.; Sperotto, A.; Patriarca, Francesca; Cerno, M.; Candoni, A.; Toffoletti, E.; Battista, M.; Medeot, M.; Damiani, Daniela; Fanin, R.
Non-myeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo 1-gen-2009 Bruno, B; Rotta, M; Patriarca, Francesca; Mattei, D; Allione, B; CARNEVALE SCHIANCA, F; Sorasio, R; Rambaldi, A; Casini, M; Parma, M; Bavaro, P; Onida, F; Busca, A; Castagna, L; Benedetti, E; Iori, Ap; Giaccone, L; Palumbo, A; Corradini, P; Fanin, Renato; Maloney, D; Storb, R; Baldi, I; Ricardi, U; Boccadoro, M.
Albumina: ricaduta delle linee guida aziendali sui consumi 1-gen-2009 Battello, C.; DE ANGELIS, V.; DELLA ROCCA, Giorgio; Dri, C.; Guarrera, G. M.; Licari, M.; Martinez, B.; Mattioni, L.; Melli, C.; Nazzi, C.; Patriarca, Francesca; Peressoni, R.; Quattrin, R.; Rinaldi, C.; Simeoni, M.; Soardo, G.; Solazzo, B.; Tottis, V.; Troncon, M.; Trovo', R.; Uzzau, Alessandro; Vendramin, I.
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation 1-gen-2009 Farina, L; Bruno, B; Patriarca, Francesca; Spina, F; Sorasio, R; Morelli, M; Fanin, Renato; Boccadoro, M; Corradini, P.
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma. 1-gen-2009 Ballerini, F; Bigazzi, C; Brioli, A; Califano, C; Casulli, Af; Cavo, Michele; Ceccolinini, M; DE VIVO, A; DI RAIMONDO, F; Fiacchini, M; Ledda, A; Offidani, M; Patriarca, Francesca; Perrone, G; Stafani, P; Tacchetti, P; Tosi, P; Volpe, S; Zamagni, E.
Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. 1-gen-2009 Skert, C.; Damiani, D.; Michelutti, A.; Patriarca, F.; Arpinati, M.; Filì, C.; Lucchi, P.; Malagola, M.; Bergonzi, C.; Roccaro, A.; Peli, A.; Ricotta, D.; Caimi, L.; Fanin, R.; Baccarani, M.; Russo, D.
Qualitative and quantitative polymerase chain reaction monitoring minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation . 1-gen-2009 Farina, L; Carniti, C; Dodero, A; Vendramin, A; Raganato, A; Spina, F; Patriarca, Francesca; Narni, F; Benedetti, F; Olivieri, A; Haematologica 2009, Corradini P. transplantation.
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts 1-gen-2009 Patriarca, Francesca; Petrucci, Mt; Bringhen, S; Baldini, L; Caravita, T; Corradini, P; Corso, A; Di Raimondo, F; Falcone, A; Ferrara, F; Morabito, F; Musto, P; Offidani, M; Petrini, M; Rizzi, R; Semenzato, G; Tosi, P; Vacca, A; Cavo, M; Boccadoro, M; Palumbo, A.
Clinical presentation, outcome and risk factors of late-onset non-infectious pulmonary complication after allogeneic transplantation 1-gen-2009 Patriarca, Francesca; Poletti, V; Costabel, U; Battista, Ml; Sperotto, A; Medeot, M; Toffoletti, Eleonora; Fanin, Renato
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma. 1-gen-2010 Engelhardt, M; Udi, J; Kleber, M; Spencer, A; Rocci, A; Knop, S; Bruno, B; Bringhen, S; Pérez Simón, Ja; Zweegman, S; Driessen, C; Patriarca, Francesca; Gramatzki, M; Terpos, E; Sezer, O; Kropff, M; Straka, C; Johnsen, He; Waage, A; Boegsted, M; Lokhorst, H; Hájek, R; Morgan, G; Boccadoro, M; Ludwig, H; Cavo, M; Polliack, A; Sonneveld, P; Einsele, H; Palumbo,
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous: a retrospective study based on the time of HLA typing and donor availability 1-gen-2010 Sarina, B; Castagna, L; Farina, L; Patriarca, F; Benedetti, F; Carella, Am; Falda, M; Guidi, S; Ciceri, F; Bonini, A; Ferrari, S; Malagola, M; Morello, E; Milone, G; Bruno, B; Mordini, N; Viviani, S; Levis, A; Giordano, L; Santoro, A; Corradini, P
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction before, and consolidation after, double autologous stem cell transplantation in newly diagnosed multiple myeloma: a randomized phase 3 study. 1-gen-2010 Cavo, M; Tacchetti, P; Patriarca, Francesca; Petrucci, Mt; Pantani, L; Galli, M; Di Raimondo, F; Crippa, C; Zamagni, E; Palumbo, A; Offidani, M; Corradini, P; Narni, F; Spadano, A; Pescosta, N; Lambertenghi Deliliers, G; Ledda, A; Cellini, C; Caravita, T; Tosi, P; Baccarani, M; GIMEMA Italian Myeloma, Network
Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin. 1-gen-2010 Cini, M; Zamagni, E; Valdré, L; Palareti, G; Patriarca, Francesca; Tacchetti, P; Legnani, C; Catalano, L; Masini, L; Tosi, P; Gozzetti, A; Cavo, M.
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients. 1-gen-2010 Benevolo, G; Boccadoro, M; Bringhen, S; Callea, V; Cangialosi, C; Cavalli, M; Cavo, Michele; DE ROSA, L; Evangelista, A; Falcone, Ap; Gaidano, G; Gentili, S; Genuardi, M; Grasso, M; Guglielmelli, T; Larocca, A; Levi, A; Liberati, Am; Musto, P; Nozzoli, C; Palumbo, A; Patriarca, Francesca; Ria, R; Rizzo, V; Rossi, D.
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial. 1-gen-2010 Baldini, L; Benevolo, G; Boccadoro, M; Bringhen, S; Callea, V; Cavalli, M; Ciccone, G; Falcone, Ap; Gottardi, D; Grasso, M; Guglielmelli, T; Larocca, A; Leonardi, G; Montefusco, V; Morabito, F; Musto, P; Nozzoli, C; Offidami, M; Palumbo, A; Patriarca, Francesca; Petrucci, Mp; Ria, R; Rizzo, M; Rossi, D.
Mostrati risultati da 51 a 100 di 227
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile